Alison was diagnosed with type 1 Gaucher when she was 22 years old, after experiencing moderate anemia and fatigue.3
After speaking with her doctor about risks and benefits of treatment, she and her doctor chose VPRIV. She was treated with VPRIV for several years at an infusion center and then switched to substrate reduction therapy (SRT) when it became available. After some time on SRT she elected to switch back to VPRIV and has remained on VPRIV since.
Alison’s career demands much of her time, so she now receives her 60-minute VPRIV infusion at home.4
VPRIV is a 60-minute infusion taken once every other week, which may be administered at home under the supervision of a healthcare professional.4
See the Dosing and Infusion Guide for more information.VPRIV Dosing & Infusion Guide
Looking to start your patients on VPRIV? Start the process by downloading a OnePath® Start Form and filling it in with your patients to begin. Please contact OnePath® at 1-866-888-0660 with any questions.VPRIV OnePath® Start Form
Download the full VPRIV Patient Profiles here.VPRIV Patient Profiles